VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,084,079 | -10.6% | 40,285 | 0.0% | 0.96% | +27.2% |
| Q2 2023 | $1,212,993 | -6.9% | 40,285 | 0.0% | 0.75% | +7.1% |
| Q1 2023 | $1,303,232 | +12.9% | 40,285 | 0.0% | 0.70% | +8.5% |
| Q4 2022 | $1,154,579 | +20.8% | 40,285 | +1.6% | 0.65% | +2.7% |
| Q3 2022 | $956,000 | -11.9% | 39,637 | 0.0% | 0.63% | -21.8% |
| Q2 2022 | $1,085,000 | -28.6% | 39,637 | 0.0% | 0.81% | -32.3% |
| Q1 2022 | $1,520,000 | +19.8% | 39,637 | 0.0% | 1.19% | +21.9% |
| Q4 2021 | $1,269,000 | +10.5% | 39,637 | +1.7% | 0.98% | +4.5% |
| Q3 2021 | $1,148,000 | -13.2% | 38,960 | 0.0% | 0.94% | -13.6% |
| Q2 2021 | $1,323,000 | +4.5% | 38,960 | 0.0% | 1.08% | -0.5% |
| Q1 2021 | $1,266,000 | -9.8% | 38,960 | 0.0% | 1.09% | -11.5% |
| Q4 2020 | $1,403,000 | -7.5% | 38,960 | +0.5% | 1.23% | -9.6% |
| Q3 2020 | $1,517,000 | -36.0% | 38,754 | -40.0% | 1.36% | -29.8% |
| Q2 2020 | $2,369,000 | -0.0% | 64,604 | -37.2% | 1.94% | +5.4% |
| Q1 2020 | $2,370,000 | -27.6% | 102,878 | -8.0% | 1.84% | +14.7% |
| Q4 2019 | $3,275,000 | +6.9% | 111,876 | -2.5% | 1.60% | -2.0% |
| Q3 2019 | $3,064,000 | -11.9% | 114,747 | -15.7% | 1.64% | -11.3% |
| Q2 2019 | $3,478,000 | +1.0% | 136,102 | -11.4% | 1.84% | +0.5% |
| Q1 2019 | $3,444,000 | 0.0% | 153,627 | -5.9% | 1.84% | -2.7% |
| Q4 2018 | $3,444,000 | +14.5% | 163,302 | +0.5% | 1.88% | +38.3% |
| Q3 2018 | $3,009,000 | -26.4% | 162,484 | -11.3% | 1.36% | -16.0% |
| Q2 2018 | $4,086,000 | +3.7% | 183,159 | +2.1% | 1.62% | -1.3% |
| Q1 2018 | $3,942,000 | -41.2% | 179,345 | -37.8% | 1.64% | -37.2% |
| Q4 2017 | $6,706,000 | +7.9% | 288,541 | +6.6% | 2.62% | +7.3% |
| Q3 2017 | $6,213,000 | +4.0% | 270,610 | 0.0% | 2.44% | -6.2% |
| Q2 2017 | $5,975,000 | +20.9% | 270,610 | +24.9% | 2.60% | +18.4% |
| Q1 2017 | $4,941,000 | +9.0% | 216,610 | 0.0% | 2.20% | +9.3% |
| Q4 2016 | $4,531,000 | – | 216,610 | – | 2.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |